Overall Status

Active, not recruiting (2)

Unknown status (1)

Phase

phase 3 (2)

n/a (1)

Sponsor

Gamida Cell ltd (1)

Massachusetts General Hospital (1)

Medical College of Wisconsin (1)

Collaborator

Blood and Marrow Transplant Clinical Trials Network (1)

National Cancer Institute (NCI) (1)

National Heart, Lung, and Blood Institute (NHLBI) (1)

National Marrow Donor Program (1)

Intervention

cord blood unit (1)

cyclophosphamide (1)

haploidentical bone marrow/kidney (1)

methotrexate (1)

mobilized peripheral blood stem cell graft with tacrolimus/methotrexate (1)

mobilized peripheral blood stem cell graft with tacrolimus/mycophenolate mofetil/post-transplant cyclophosphamide (1)

mycophenolate mofetil (1)

nicord® (omidubicel) (1)

tacrolimus (1)

Study Documents

Intervention Type

drug (2)

procedure (2)

other (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

chronic myelogenous leukemia (cml)

Showing NaN - NaN of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia Trial in United States (Mobilized Peripheral Blood Stem Cell

Active, not recruiting

Acute Leukemia
+3 more

Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
+5 more

Birmingham, Alabama
+38 more

Oct 25, 2021

Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML) Trial in Worldwide (NiCord®

Active, not recruiting

Hematological Malignancies
+6 more

NiCord® (omidubicel)
Cord Blood Unit

Los Angeles, California
+51 more

Jan 7, 2021

Chronic Kidney Disease, Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) Trial in Boston (Haploidentical Bone

Unknown status

Chronic Kidney Disease
+16 more

Haploidentical Bone Marrow/Kidney

Boston, Massachusetts

Massachusetts General Hospital

Mar 21, 2017